Charlotte Jones-Burton

Charlotte Jones-Burton (board member) discloses dealings in bluebird bio, Inc. to SEC (Form 4). Between 7 March 2022 and 2 June 2025, the trades on record add up to 6 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 3 June 2025 came the latest disclosure, a transaction in bluebird bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.